Entasis Therapeutics Holdings Inc.
ETTXDelisted Jul 11, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724344
Entasis Therapeutics Holdings Inc. was delisted on Jul 11, 2022; its insiders filed their last Form 4 on Jul 13, 2022; 27 institutions reported holding it in 13F filings for Q2 2022, worth $12.5M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Entasis Therapeutics Holdings Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ETTX is no longer listed, and 13F filings after Q2 2022 list far fewer holders. See Q2 2022
- Institutional holders
- 0
- −27 vs. Q2 2022
- Shares held
- 0
- −5.70M (−100.0%) vs. Q2 2022
- Total value
- $0
- −$12.5M (−100.0%) vs. Q2 2022
- New holders
- 0
- 0 more added
- Sold out
- 27
- 0 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 27 | $12.5M |
| Q1 2022 | 22 | $5.77M |
| Q4 2021 | 28 | $7.24M |
| Q3 2021 | 29 | $11.3M |
| Q2 2021 | 24 | $8.89M |
| Q1 2021 | 25 | $9.34M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Entasis Therapeutics Holdings Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gardner Lewis Asset Management L P | 0 | $0 | 0.00% | −1,249,778−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −1,131,772−100.0% | Sold out |
| TPG GP A, LLC | 0 | $0 | 0.00% | −1,020,748−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −502,622−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −393,563−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −350,345−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −180,827−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −155,614−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −135,323−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −132,600−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −83,705−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −70,688−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −59,100−100.0% | Sold out |
| Knott David M Jr | 0 | $0 | 0.00% | −41,700−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −40,900−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −34,356−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −30,262−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −23,160−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,027−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −14,236−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,635−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −12,179−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,426−100.0% | Sold out |
| Bollard Group LLC | 0 | $0 | 0.00% | −1,448−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,125−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Trustcore Financial Services, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |